Építés alatt – nem éles oldal
Belépés
Csak meghívásosFázis nélkül

Far-Infrared Socks for Neuropathic Pain and Nerve Function in Diabetic Patients

A legfontosabb adatok

Ki végzi
TC Erciyes University
Hol
Törökország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Csak meghívásos
Résztvevők
50 fő, tervezett
Kezdés
2025. febr. 2.
Tervezett befejezés
2026. jún. 30.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
A vizsgált kezelések
  • Far-Infrared Radiation (FIR) Socks
  • Placebo Socks
A regiszteradat frissítve
2025. március 19.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with mild to moderate nerve damage in the feet and legs caused by diabetes (diabetic peripheral neuropathy). They will wear special far-infrared socks or look-alike placebo socks daily.

Életkor
19 years and older
Nem
All sexes
A betegség stádiuma
Diabetic peripheral neuropathy of mild to moderate severity, based on clinical evaluation. People must live in Kayseri and get treatment there.
Korábbi kezelés
No neuropathic pain medicine for at least 3 months before joining. No non-drug treatment for the neuropathy. No recent changes in diabetes medicine.
Biomarker vagy leletérték
HbA1C below 8.5% (69 mmol/mol) during the study. BMI between 25 - 35. Non-smoker for at least 6 months.

A részvétel fő kizáró okai

  • Diabetic foot ulcers, or unable to walk on your own
  • Severe artery disease in the legs (Ankle Brachial Index below 0.4), or coronary artery disease
  • Liver failure or kidney failure (on dialysis)
  • Dementia or other nerve or memory problems, or chronic alcohol or drug use
  • Pregnant, breastfeeding or trying to get pregnant

A regiszter feltételei, szó szerint

Mind a 25 feltétel megnézéseKevesebb

Ki vehet részt

  • Diagnosed with diabetic peripheral neuropathy (DPN) with mild to moderate severity based on clinical evaluation
  • Oriented to person, place, and time (cognitively intact)
  • Residing in Kayseri and receiving treatment in the city
  • HbA1C level below 8.5% during the study period
  • Non-smoker for at least 6 months
  • Not using neuropathic pain medication for at least 3 months before enrollment
  • Body Mass Index (BMI) between 25 - 35
  • Able to be contacted by phone for follow-up
  • Willing to participate and provide informed consent

Ki nem vehet részt

  • Candidates for surgery during the intervention period
  • Receiving non-pharmacological treatment for diabetic peripheral neuropathy (DPN)
  • Receiving physiotherapy at any point during the study period
  • Severe peripheral artery disease (Ankle Brachial Index (ABI) < 0.4)
  • Liver failure or renal failure (dialysis patients)
  • Coronary artery disease
  • Neurological or cognitive impairments (e.g., dementia, Alzheimer's disease)
  • Recent changes in diabetes medication or newly diagnosed with diabetes
  • Use of cytotoxic or immunosuppressive agents or history of radiation therapy
  • Presence of diabetic foot ulcers
  • Non-mobilized individuals (unable to walk independently)
  • Lower extremity arthroplasty or orthosis indication during the intervention period
  • Chronic alcohol or substance use
  • Severe anemia, vitamin B12 deficiency, or iron deficiency anemia
  • Neurological, cardiovascular, or orthopedic damage affecting the lower extremities
  • Pregnant, breastfeeding, or attempting to conceive

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This study aims to evaluate the effectiveness of far-infrared radiation (FIR) emitting socks in improving neuropathic pain, nerve conduction, and quality of life in patients with diabetic peripheral neuropathy (DPN). It is the first comprehensive study in Turkey investigating FIR technology for DPN treatment and offers an alternative approach to traditional methods.The study will be conducted at Erciyes University Gevher Nesibe Hospital between February 2025 and June 2026 as a randomized controlled trial (RCT) with a triple-blind design. Participants will be assigned to either the FIR socks group or the placebo group, with both groups receiving two pairs of socks to wear daily. Assessments will include the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Scale, the Neuropathic Pain Impact on Quality of Life (NePIQoL) questionnaire, and the Visual Analog Scale (VAS) for patient-reported outcomes. Electroneuromyography (ENMG) testing will also be performed before and after the intervention to assess nerve function.

A teljes eredeti leírásKevesebb

This research is expected to provide clinical evidence on FIR socks as a non-pharmacological treatment for neuropathic pain, contributing to improved patient care and the development of innovative medical technologies in Turkey.

A vizsgálat 2 csoportja

  • Experimental GroupA vizsgált kezelés

    Patients will be selected from those attending endocrinology and neurology clinics or hospitalized and meeting the inclusion criteria. Participants will complete the Patient Information Form, LANSS Scale, and NePIQoL forms in a quiet room in the endocrinology ward. The Ankle Brachial Index will be evaluated to exclude peripheral arterial disease. If ENMG and lab findings are unavailable, patients will be referred for necessary tests. They will receive two pairs of FIR socks to be worn at least 8 hours daily, along with usage training. Contact information will be collected. Participants will be called three times to assess compliance and comfort via VAS. After three months, they will return for a final evaluation, including an ENMG scan by neurology specialists, and complete the LANSS Scale and NePIQoL forms again.

    Kezelés: Far-Infrared Radiation (FIR) Socks

  • Placebo Socks GroupPlacebo, összehasonlításként

    Placebo group patients will be selected from those attending endocrinology and neurology clinics or hospitalized and meeting inclusion criteria. Participants will complete the Patient Information Form, LANSS Scale, and NePIQoL forms in a quiet room. The Ankle Brachial Index will be evaluated to exclude peripheral arterial disease. If ENMG and lab findings are unavailable, patients will be referred for necessary tests. They will receive two pairs of non-FIR socks to be worn at least 8 hours daily, along with usage training. Contact information will be collected. Participants will be called three times to assess compliance and comfort via VAS. After three months, they will return for a final evaluation, including an ENMG scan by neurology specialists, and complete the LANSS Scale and NePIQoL forms again.

    Kezelés: Placebo Socks

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Effect of Far-Infrared Emitting Socks on Neuropathic Pain, Nerve Conduction, and Quality of Life in Patients With Diabetic Peripheral Neuropathy: A Randomized Controlled Trial
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
A regiszteradat frissítve
2025. március 19.